Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 2
2012 3
2013 1
2014 7
2015 17
2016 20
2017 27
2018 20
2019 8
2020 9
Text availability
Article attribute
Article type
Publication date

Search Results

100 results
Results by year
Filters applied: . Clear all
Page 1
An overview of application of silver nanoparticles for biomaterials in dentistry.
Bapat RA, Chaubal TV, Joshi CP, Bapat PR, Choudhury H, Pandey M, Gorain B, Kesharwani P. Bapat RA, et al. Among authors: Kesharwani P. Mater Sci Eng C Mater Biol Appl. 2018 Oct 1;91:881-898. doi: 10.1016/j.msec.2018.05.069. Epub 2018 May 25. Mater Sci Eng C Mater Biol Appl. 2018. PMID: 30033323 Review.
Systematic review of metformin monotherapy and dual therapy with sodium glucose co-transporter 2 inhibitor (SGLT-2) in treatment of type 2 diabetes mellitus.
Molugulu N, Yee LS, Ye YT, Khee TC, Nie LZ, Yee NJ, Yee TK, Liang TC, Kesharwani P. Molugulu N, et al. Among authors: Kesharwani P. Diabetes Res Clin Pract. 2017 Oct;132:157-168. doi: 10.1016/j.diabres.2017.07.025. Epub 2017 Jul 25. Diabetes Res Clin Pract. 2017. PMID: 28797524 Review.
Dynamics of Prolyl Hydroxylases Levels During Disease Progression in Experimental Colitis.
Bakshi HA, Mishra V, Satija S, Mehta M, Hakkim FL, Kesharwani P, Dua K, Chellappan DK, Charbe NB, Shrivastava G, Rajeshkumar S, Aljabali AA, Al-Trad B, Pabreja K, Tambuwala MM. Bakshi HA, et al. Among authors: Kesharwani P. Inflammation. 2019 Dec;42(6):2032-2036. doi: 10.1007/s10753-019-01065-3. Inflammation. 2019. PMID: 31377947 Free PMC article.
Carbon dots: emerging theranostic nanoarchitectures.
Mishra V, Patil A, Thakur S, Kesharwani P. Mishra V, et al. Among authors: Kesharwani P. Drug Discov Today. 2018 Jun;23(6):1219-1232. doi: 10.1016/j.drudis.2018.01.006. Epub 2018 Jan 31. Drug Discov Today. 2018. PMID: 29366761 Review.
Tuberculosis Treated by Multiple Drugs: An Overview.
Singh G, Kesharwani P, Srivastava AK. Singh G, et al. Among authors: Kesharwani P. Curr Drug Deliv. 2018;15(3):312-320. doi: 10.2174/1567201814666171120125916. Curr Drug Deliv. 2018. PMID: 29165080 Review.
Nanotechnology based approaches for anti-diabetic drugs delivery.
Kesharwani P, Gorain B, Low SY, Tan SA, Ling ECS, Lim YK, Chin CM, Lee PY, Lee CM, Ooi CH, Choudhury H, Pandey M. Kesharwani P, et al. Diabetes Res Clin Pract. 2018 Feb;136:52-77. doi: 10.1016/j.diabres.2017.11.018. Epub 2017 Nov 28. Diabetes Res Clin Pract. 2018. PMID: 29196152 Review.
Immune checkpoint inhibitors: a promising anticancer therapy.
Singh S, Hassan D, Aldawsari HM, Molugulu N, Shukla R, Kesharwani P. Singh S, et al. Among authors: Kesharwani P. Drug Discov Today. 2020 Jan;25(1):223-229. doi: 10.1016/j.drudis.2019.11.003. Epub 2019 Nov 15. Drug Discov Today. 2020. PMID: 31738877 Review.
A comprehensive review on polyelectrolyte complexes.
Meka VS, Sing MKG, Pichika MR, Nali SR, Kolapalli VRM, Kesharwani P. Meka VS, et al. Among authors: Kesharwani P. Drug Discov Today. 2017 Nov;22(11):1697-1706. doi: 10.1016/j.drudis.2017.06.008. Epub 2017 Jul 3. Drug Discov Today. 2017. PMID: 28683256 Review.
100 results
Jump to page